About NeuroOne
NeuroOne is a publicly listed company based in Eden Prairie (United States) founded in 2017. AI-enabled diagnostic and treatment devices for neurological diseases are developed. It operates on a Direct-to-Consumer (D2C) and HealthTech model. NeuroOne offers products and services including OneRF™ Ablation System, Evo® sEEG Electrode, and Evo® Cortical Electrode. Its focus areas include Medical Devices and Neurostimulation Devices. Its legal entity is NeuroOne Medical Technologies Corporation. Similar companies include Ceribell, Seer and BrainScope; 3 of its 3 listed similar companies have raised funding.
Company details
NeuroOne Medical Technologies Corporation is engaged in the development of high-definition, minimally invasive diagnostic and therapeutic devices for neurological applications. The companys primary focus is on epilepsy and the expanding neurostimulation device market. Its portfolio includes innovative thin-film electrode technologies such as the OneRF Ablation System, Evo sEEG Electrode, and Evo Cortical Electrode, which are designed for brain monitoring, mapping, and treatment. Solutions are developed to provide less invasive options for patients, aiming to improve outcomes in neurosurgical procedures. NeuroOne collaborates with leading experts to explore applications beyond epilepsy, targeting a broader range of neurological conditions.
- Latest Funding Round$12.5M (USD), Post-IPO
Jan 2021
Products & Services of NeuroOne
NeuroOne offers a comprehensive portfolio of products and services, including OneRF™ Ablation System, Evo® sEEG Electrode, and Evo® Cortical Electrode.
Radiofrequency ablation system for neurosurgical lesion creation.
Electrode for brain signal recording and stimulation.
Electrode for surface brain signal monitoring use.
Funding Insights of NeuroOne
- Total Rounds 2
- Last Round Post-IPO — $12.5M
- First Round $135,000
(Aug 2020)
All 2 funding rounds of NeuroOne with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $12.5M | Post-IPO | – | – | – |
| Aug 2020 | $135,000 | Post-IPO | – | – | – |
People of NeuroOne
24 people are tracked at NeuroOne (7 in leadership, 14 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Steve Mertens | Chief Technology Officer | Leadership |
Hijaz Haris | Vice President Of Marketing | Leadership |
Ron Mcclurg | Chief Financial Officer | Leadership |
Camilo Diaz Botia | Vice President Of Engineering | Leadership |
Dave Rosa | President And CEO | Leadership |
Mark Christianson | VP Of Business Development & Marketing | Leadership |
Christopher Volker | Chief Operating Officer | Leadership |
Parag Patil | AI Advisory Board Member | Board & advisors |
Kip Ludwig | Chairman, AI Advisory Board | Board & advisors |
Gregory J. Esper | Scientific Advisory Board Member | Board & advisors |
Justin Williams | Scientific Advisory Board Member | Board & advisors |
Ed Andrle | Director | Board & advisors |
Douglas J. Weber | AI Advisory Board Member | Board & advisors |
Joseph Madsen | Scientific Advisory Board Member | Board & advisors |
Jacob Vogelstein | AI Advisory Board Member | Board & advisors |
Cristin Welle | AI Advisory Board Member | Board & advisors |
Jamie Van Gompel | Scientific Advisory Board Member | Board & advisors |
Greg Worrell | Chairman, Scientific Advisory Board | Board & advisors |
Paul Buckman | Chairman, Board of Directors | Board & advisors |
Jeff Mathiesen | Director | Board & advisors |
4 more people are available in the full profile.
Complete people profiles for NeuroOne
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NeuroOne
4 dated milestones of NeuroOne across 4 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroOne is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $135K.
- Funding Latest funding round, Post-IPO, of $12.5M.
Similar companies to NeuroOne
NeuroOne has 3 listed similar companies in our database, 3 of them funded. They include Ceribell, Seer and BrainScope.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ceribell.com | 2014 | Mountain View, United States | $187.52M | 218 | Portable EEG devices for point-of-care seizure diagnosis are provided. | |
| seer.bio | 2017 | San Francisco, United States | $127.5M | 89 | Proteomics platform developed for early cancer and neurological disease detection. | |
| brainscope.com | 2006 | Bethesda, United States | $62.15M | 38 | Developer of AI-driven EEG platform transforming brain electrical activity into insights |
Detailed similar companies of NeuroOne
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as NeuroOne (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuroone
Complete news archive for NeuroOne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroOne
NeuroOne was founded in 2017 and raised its 1st funding round 3 years after it was founded.
NeuroOne is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
NeuroOne Medical Technologies Corporation is engaged in the development of high-definition, minimally invasive diagnostic and therapeutic devices for neurological applications. The companys primary focus is on epilepsy and the expanding neurostimulation device market. Its portfolio includes innovative thin-film electrode technologies such as the OneRF Ablation System, Evo sEEG Electrode, and Evo Cortical Electrode, which are designed for brain monitoring, mapping, and treatment. Solutions are developed to provide less invasive options for patients, aiming to improve outcomes in neurosurgical procedures. NeuroOne collaborates with leading experts to explore applications beyond epilepsy, targeting a broader range of neurological conditions.
NeuroOne's top competitors include Ceribell, BrainScope and Seer.
NeuroOne offers OneRF™ Ablation System, Evo® sEEG Electrode, and Evo® Cortical Electrode.
NeuroOne operates through Neuroone Medical Technologies Corporation.